文献速递新发突发、热带与寄生虫病

寨卡病毒疫苗研发

Zika Virus Vaccine Development.
PubMed 文献 · J Infect Dis · 2017-01-01

寨卡病毒在巴西出现并与小头畸形和吉兰-巴雷综合征相关,加速了疫苗研发。基于黄病毒疫苗研发经验、E二聚体作为关键抗原靶点的认识及中和机制理解,多种疫苗策略以前所未有的速度进入临床评价,包括核酸疫苗、全灭活病毒疫苗、减毒活疫苗或嵌合病毒疫苗以及蛋白或病毒样颗粒疫苗。世界卫生组织宣布寨卡病毒为国际关注的突发公共卫生事件后一年内,多个候选疫苗进入临床试验,目前共7个产品,另有40多个候选疫苗处于临床前开发阶段。

要点

  • 寨卡病毒与巴西小头畸形和吉兰-巴雷综合征相关,推动疫苗加速研发。
  • 多种疫苗策略已进入临床评价,包括核酸、全灭活病毒、减毒活或嵌合病毒、蛋白或病毒样颗粒疫苗。
  • WHO宣布国际关注的突发公共卫生事件后一年内,7个产品进入临床试验,另有40多个候选疫苗处于临床前开发。

核心结论

  • 疫苗研发的快速进展表明,当存在充分的先前知识、紧急资金和机构间合作时,政府、公共卫生组织和科学界有能力应对大流行威胁,并可作为未来新发传染病防范的范式。

研究设计与样本

  • 本文为综述,基于既往黄病毒疫苗研发项目、黄病毒颗粒结构知识、E二聚体作为关键抗原靶点的定义以及对中和机制的深入理解,汇总多种寨卡疫苗策略的研发进展。

主要发现

  • 核酸疫苗(DNA和信使RNA)、全灭活病毒疫苗、减毒活疫苗或嵌合病毒疫苗以及蛋白或病毒样颗粒疫苗等多种疫苗策略已推进至临床评价阶段。
  • 世界卫生组织宣布寨卡病毒为国际关注的突发公共卫生事件后一年内,多个候选疫苗进入临床试验,目前共计7个产品,另有40多个候选疫苗处于临床前开发阶段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The emergence of Zika virus in Brazil and its association with microcephaly and Guillain-Barré syndrome led to accelerated vaccine development efforts. Based on prior flavivirus vaccine development programs, knowledge of flavivirus particle structure, definition of E dimers as the key antigenic target, and deep understanding of neutralizing mechanisms, multiple vaccine strategies have advanced to the stage of clinical evaluation with unprecedented speed. These include nucleic acid (DNA and messenger RNA), whole-inactivated virus, live-attenuated or chimeric virus, and protein or viruslike particle vaccines. Within a year from the declaration by the World Health Organization of Zika virus as a Public Health Emergency of International Concern, multiple vaccine candidates entered clinical trials, now totaling 7 products with an additional 40-plus candidate vaccines in preclinical development. The rapid progress in vaccine development demonstrates the capacity of governments, public health organizations, and the scientific community to respond to pandemic threats when sufficient prior knowledge exists, emergency funding is made available, and interagency cooperation is achieved and serves as a paradigm for preparing for future emerging infectious diseases.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Morabito KM, Graham BS. Zika Virus Vaccine Development. J Infect Dis. 2017. PMID: 29267918. doi:10.1093/infdis/jix464

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。